These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 6398313)
1. First observations on high-dosed and long-term thymopentin treatment in active rheumatoid arthritis. Molin L; Schmid F; Bolla K Int J Clin Pharmacol Res; 1984; 4(6):445-9. PubMed ID: 6398313 [TBL] [Abstract][Full Text] [Related]
2. Interim results on the clinical effects of i.v. administered thymopentin in active rheumatoid arthritis. Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K Int J Clin Pharmacol Res; 1984; 4(6):451-7. PubMed ID: 6398314 [TBL] [Abstract][Full Text] [Related]
3. Thymopoietin pentapeptide (thymopentin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short- and longterm clinical studies. Veys EM; Mielants H; Verbruggen G; Spiro T; Newdeck E; Power D; Goldstein G J Rheumatol; 1984 Aug; 11(4):462-6. PubMed ID: 6384507 [TBL] [Abstract][Full Text] [Related]
4. [Immunomodulating therapy in chronic polyarthritis with thymopentin. A multicenter placebo-controlled study of 119 patients]. Lemmel EM; Bach GL; Bolten W; Brackertz D; Fahmy Z; Mattern H; Stroehmann I; Wittenborg A Dtsch Med Wochenschr; 1988 Feb; 113(5):172-6. PubMed ID: 3276492 [TBL] [Abstract][Full Text] [Related]
5. [Telethermographic evaluation of the intra-articular administration of thymopentin in rheumatoid arthritis of the knee]. Pappalardo A; Sallì L; Campisi D; Scalici G; Di Marco C; Martorana U Clin Ter; 1989 Mar; 128(5):321-7. PubMed ID: 2524320 [TBL] [Abstract][Full Text] [Related]
6. Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients. Franchimont P; Hauwaert C; Bolla K Surv Immunol Res; 1985; 4 Suppl 1():81-6. PubMed ID: 3898297 [TBL] [Abstract][Full Text] [Related]
7. Some observations on various dose regimens of thymopentin treatment in rheumatoid arthritis. Molin L; Schmid F; Bolla K Surv Immunol Res; 1985; 4 Suppl 1():76-80. PubMed ID: 3898296 [TBL] [Abstract][Full Text] [Related]
8. The effect of thymopentin treatment on the relapse rate in frequently relapsing herpes simplex virus infections. Haneke E; Bolla K; Degreef H; Djawari D; Demaubeuge J; Molin L; Panconesi E; Schöpf E; Stengel R; Stingl G Int J Clin Pharmacol Res; 1984; 4(6):439-43. PubMed ID: 6085327 [TBL] [Abstract][Full Text] [Related]
9. Treatment of active rheumatoid arthritis with slow intravenous injections of thymopentin. A double-blind placebo-controlled randomised study. Malaise MG; Hauwaert C; Franchimont P; Danneskiold-Samsoe B; Bach-Andersen R; Gross D; Gerber H; Gerschpacher H; Stocker H; Bolla K Lancet; 1985 Apr; 1(8433):832-6. PubMed ID: 2858708 [TBL] [Abstract][Full Text] [Related]
10. Confirmative study of the effectiveness of thymopentin in active rheumatoid arthritis. Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K Surv Immunol Res; 1985; 4 Suppl 1():87-93. PubMed ID: 3898298 [TBL] [Abstract][Full Text] [Related]
11. [Thymopentin in the treatment of recurrent condylomata acuminata]. Ghetti P; Negosanti M; Andriani GC; Beltrandi E; Maldini M Minerva Ginecol; 1989 Feb; 41(2):113-6. PubMed ID: 2664577 [TBL] [Abstract][Full Text] [Related]
12. Preliminary results on clinical and immunological effects of thymopentin in AIDS. Clumeck N; van de Perre P; Mascart-Lemone F; Cran S; Bolla K; Duchateau J Int J Clin Pharmacol Res; 1984; 4(6):459-63. PubMed ID: 6398315 [TBL] [Abstract][Full Text] [Related]
13. Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy. Barcellini W; Meroni PL; Frasca D; Sguotti C; Borghi MO; Uberti-Foppa C; Buzzetti P; Lazzarin A; Doria G; Moroni M Clin Exp Immunol; 1987 Mar; 67(3):537-43. PubMed ID: 3301099 [TBL] [Abstract][Full Text] [Related]
14. Immunomodulation with thymopentin in humans. Bolla K; Duchateau J; Delespesse G; Servais G Int J Clin Pharmacol Res; 1984; 4(6):431-8. PubMed ID: 6398312 [TBL] [Abstract][Full Text] [Related]
15. Thymopentin as adjuvant to hepatitis B vaccination. Results from three double-blind studies. Grob PJ; Binswanger U; Blumberg A; Gloor HJ; Hany A; Herwig W; Iselin H; Zàruba K; Bolla K Surv Immunol Res; 1985; 4 Suppl 1():107-15. PubMed ID: 3898281 [TBL] [Abstract][Full Text] [Related]
16. [A case of juvenile rheumatoid arthritis treated with thymopentin]. Tucciarone L; Felici W; Greco L; Mechelli A Minerva Pediatr; 1989 Feb; 41(2):109-11. PubMed ID: 2661988 [TBL] [Abstract][Full Text] [Related]
17. Thymopentin treatment in genital warts of long duration. Fransen L; Anthoons J; Hoogewijs G; Bolla K Cancer Detect Prev; 1988; 12(1-6):503-9. PubMed ID: 3052838 [TBL] [Abstract][Full Text] [Related]
18. Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis. Veys EM; Huskisson EC; Rosenthal M; Vischer TL; Mielants H; Thrower PA; Scott J; Ott H; Scheijgrond H; Symoens J Ann Rheum Dis; 1982 Oct; 41(5):441-3. PubMed ID: 6751241 [TBL] [Abstract][Full Text] [Related]
19. A prospective study of thymopentin in severely burned patients. Waymack JP; Jenkins M; Warden GD; Solomkin J; Law E; Hummel R; Miller A; Alexander JW Surg Gynecol Obstet; 1987 May; 164(5):423-30. PubMed ID: 3554564 [TBL] [Abstract][Full Text] [Related]